Global pertussis resurgence: An urgent call for macrolide resistance monitoring - 06/12/24
Doi : 10.1016/j.jinf.2024.106336
Mengyang Guo, Siyu Chen, Wei Gao, Lin Yuan, Kaihu Yao ⁎ 
Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, National Key Discipline of Pediatrics, Laboratory of Infection and Microbiology, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing 100045, China
*Correspondence to: Beijing Children's Hospital, Capital Medical University, No. 56 Nanlishi Road, Xicheng District, Beijing, China.Beijing Children's Hospital, Capital Medical UniversityNo. 56 Nanlishi Road, Xicheng DistrictBeijingChina
Highlights |
• | China faces the world’s most severe epidemic of macrolide-resistant pertussis. |
• | High MRBP prevalence correlates with rising pertussis cases and genotype shifts. |
• | Urgent global MRBP monitoring needed to combat the growing pertussis epidemic. |
© 2024
The Author(s). Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 89 - N° 6
Article 106336- décembre 2024 Retour au numéro
Article précédent
- Incorporating absolute effects and GRADE assessments to enhance the interpretation of findings from meta-analyses
- Li Zheng, Ming Liu, Peng Yan, Jinhui Tian, Yang Zhang
- Genomic analysis confirmed the importation of first mPox Clade Ib case in Kerala, India from Dubai, UAE
- Anita M. Shete, Shubin Chenayil, Rima R. Sahay, CB Sindhu, Savita Yadav, Pranita Gawande, Deepak Y. Patil, Abhinendra Kumar, Sreelekshmy Mohandas, Pragya D. Yadav
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?